Quantbot Technologies LP Avidity Biosciences, Inc. Transaction History

Quantbot Technologies LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.87 - $9.37 $95,939 - $184,588	-19,700 Reduced 95.63%	900 $8,000
Q3 2023 Nov 07, 2023	BUY	$6.3 - $11.35 $88,200 - $158,900	14,000 Added 212.12%	20,600 $131,000
Q2 2023 Aug 08, 2023	BUY	$10.62 - $17.34 $70,092 - $114,444	6,600 New	6,600 $73,000
Q4 2022 Feb 13, 2023	BUY	$10.06 - $22.66 $252,807 - $569,445	25,130 Added 12565.0%	25,330 $562,000
Q3 2022 Nov 07, 2022	SELL	$15.46 - $23.43 $29,374 - $44,517	-1,900 Reduced 90.48%	200 $3,000
Q2 2022 Aug 09, 2022	BUY	$11.18 - $20.5 $20,124 - $36,900	1,800 Added 600.0%	2,100 $30,000
Q1 2022 May 16, 2022	BUY	$14.2 - $23.78 $4,260 - $7,134	300 New	300 $5,000
Q4 2021 Feb 11, 2022	SELL	$20.4 - $28.66 $6,120 - $8,598	-300 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$18.16 - $25.21 $5,448 - $7,563	300 New	300 $7,000

252

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.55B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.